- Booth: 214, Corporate Posters
BGI Americas Corporation is the leading provider of genomics and proteomics services in the Americas Region as part of BGI Genomics, a public company listed on the Shenzhen Stock Exchange. Established in 2010, BGI Americas has grown to include a presence in Boston and San Jose, serving a wide range of customers in genetics research, drug R&D, and diagnostics. We have 20 years of genomics experience helping our customers achieve their research goals by delivering rapid, high-quality results using a broad array of cost-effective, cutting-edge technologies, including our own innovative DNBseq™ sequencing technology. BGI Americas invested a state-of-the-art Mass Spec service center in its San Jose, California laboratory in 2019 to further diversify its multi-omics offerings and bioanalytical solutions. We are committed to advancing genetic research, technologies, and applications to benefit mankind.